https://onkossurgical.com/onkos-surgical-and-3d-systems-team-to-advance-personalized-surgical-oncology-solutions/ 2022-12-08T20:23:05+00:00 monthly 0.2 https://onkossurgical.com/onkos-surgicals-3rd-annual-partnership-with-msts-kicks-off-at-the-aaos-annual-meeting-in-new-orleans/ 2022-12-08T20:06:41+00:00 monthly 0.2 https://onkossurgical.com/onkos-surgical-and-insight-medical-systems-team-up-to-explore-applications-of-augmented-reality-in-musculoskeletal-oncology/ 2022-12-08T20:22:14+00:00 monthly 0.2 https://onkossurgical.com/onkos-surgical-to-launch-new-personalized-surgery-platform-with-disruptive-service-model-for-joint-sparing-tumor-surgery/ 2022-12-08T20:21:35+00:00 monthly 0.2 https://onkossurgical.com/business-update-regarding-covid-19/ 2022-12-08T20:17:47+00:00 monthly 0.2 https://onkossurgical.com/onkos-surgical-continues-its-innovation-in-musculoskeletal-oncology-and-complex-orthopaedic-reconstruction-with-the-launch-of-the-eleos-proximal-tibia-with-biogrip-technology/ 2022-12-08T20:21:00+00:00 monthly 0.2 https://onkossurgical.com/hello-world/ 2022-12-08T20:08:18+00:00 monthly 1.0 https://onkossurgical.com/onkos-surgical-announces-fda-510k-clearance-of-its-biogrip-modular-porous-collars-a-first-of-its-kind-solution-to-help-address-implant-loosening-in-orthopaedic-oncology-and-complex-revi/ 2022-12-08T20:08:39+00:00 monthly 0.2 https://onkossurgical.com/onkos-surgical-raises-15-million-in-series-c-funding/ 2022-12-08T20:08:56+00:00 monthly 0.2 https://onkossurgical.com/onkos-surgical-announces-definitive-agreement-to-acquire-the-jts-extendible-prosthesis/ 2022-12-08T20:09:24+00:00 monthly 0.2 https://onkossurgical.com/onkos-surgical-receives-fda-510k-clearance-for-3d-printed-patient-specific-pelvic-reconstruction-system/ 2022-12-08T20:09:14+00:00 monthly 0.2 https://onkossurgical.com/onkos-surgical-announces-expanded-capability-in-pediatric-musculoskeletal-oncology-and-unveils-new-manufacturing-and-innovation-center/ 2023-07-26T01:56:54+00:00 monthly 0.2 https://onkossurgical.com/onkos-surgical-announces-first-fda-de-novo-approval-of-an-antibacterial-coating-for-tumor-and-revision-orthopaedic-implants/ 2024-04-08T15:17:32+00:00 monthly 0.2 https://onkossurgical.com/horizon-technology-finance-provides-35-million-venture-loan-facilityto-onkos-surgical-to-accelerate-commercialization-of-novel-antibacterial-implant-technology/ 2025-01-08T20:27:43+00:00 monthly 0.2 https://onkossurgical.com/onkos-surgical-successfully-completes-groundbreaking-first-in-human-cases-using-nanocept-antibacterial-technology/ 2025-01-09T19:38:04+00:00 monthly 0.2 https://onkossurgical.com/onkos-nanocept-antibacterial-technology-featured-in-bonezone/ 2025-01-15T15:05:17+00:00 monthly 0.2 https://onkossurgical.com/onkos-surgical-receives-fda-510k-clearance-for-eleos-proximal-tibia-with-nanocept-antibacterial-technology/ 2025-10-21T13:25:11+00:00 monthly 0.2 https://onkossurgical.com/nanocept-innovation-center-ribbon-cutting-ceremony/ 2026-02-19T18:23:48+00:00 monthly 0.2 https://onkossurgical.com/onkos-surgical-announces-initiation-of-522-post-market-surveillance-study-of-the-eleos-limb-salvage-system-with-nanocept-antibacterial-implant-technology/ 2026-02-19T17:35:38+00:00 monthly 0.2